Nuvation Bio's total assets for Q3 2024 were $571.58M, a decrease of -3.90% from the previous quarter. NUVB total liabilities were $68.86M for the fiscal quarter, a 9.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.